Viracta Therapeutics, Inc. (NASDAQ:VIRX) Short Interest Update
Viracta Therapeutics, Inc. (NASDAQ:VIRX – Get Free Report) was the recipient of a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 2,100,000 shares, a decline of 21.9% from the October 31st total of 2,690,000 shares. Approximately 7.5% of the shares of the company are […]
More Stories
Trimedyne (OTCMKTS:TMED) Shares Cross Below 200 Day Moving Average – Here’s What Happened
Shares of Trimedyne, Inc. (OTCMKTS:TMED – Get Free Report) crossed below its two hundred day moving average during trading on...
Trimedyne (OTCMKTS:TMED) Shares Cross Below 200 Day Moving Average – Here’s What Happened
Shares of Trimedyne, Inc. (OTCMKTS:TMED – Get Free Report) crossed below its two hundred day moving average during trading on...
Trimedyne (OTCMKTS:TMED) Shares Cross Below 200 Day Moving Average – Here’s What Happened
Shares of Trimedyne, Inc. (OTCMKTS:TMED – Get Free Report) crossed below its two hundred day moving average during trading on...
DoubleLine Income Solutions Fund (NYSE:DSL) Shares Pass Below 200-Day Moving Average – Should You Sell?
Shares of DoubleLine Income Solutions Fund (NYSE:DSL – Get Free Report) passed below its 200-day moving average during trading on...
DoubleLine Income Solutions Fund (NYSE:DSL) Shares Pass Below 200-Day Moving Average – Should You Sell?
Shares of DoubleLine Income Solutions Fund (NYSE:DSL – Get Free Report) passed below its 200-day moving average during trading on...
DoubleLine Income Solutions Fund (NYSE:DSL) Shares Pass Below 200-Day Moving Average – Should You Sell?
Shares of DoubleLine Income Solutions Fund (NYSE:DSL – Get Free Report) passed below its 200-day moving average during trading on...